Nicotinell Spearmint (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Spearmint, is a nicotine replacement therapy presented as a buccal delivery system for oromucosal use. It is intended to aid adult smokers who wish to quit by reducing nicotine withdrawal symptoms and supporting gradual cessation, and it is marketed in the European Union.

GNH USA supplies Nicotinell Spearmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, ensuring quality and regulatory compliance across markets.

Nicotinell Spearmint is a nicotine replacement product that addresses nicotine dependence and supports smoking cessation efforts. - Smoking cessation: helps adult smokers reduce withdrawal symptoms and gradually quit tobacco use. - Nicotine dependence: provides controlled nicotine to support cessation attempts. - Relapse prevention: assists individuals who have recently quit to maintain abstinence.

Nicotinell Spearmint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or burning sensation in the oral cavity. - Hiccups: brief, involuntary diaphragmatic contractions. - Nausea: feeling of queasiness or upset stomach. - Throat irritation: scratchy or uncomfortable throat. - Increased salivation: excess saliva production. - Dyspepsia: indigestion or mild abdominal discomfort.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain: unexpected discomfort in the chest area. - Severe dizziness: pronounced light‑headedness or vertigo. - Cardiac arrhythmia: irregular heart rhythm. - Severe mouth ulceration: large or persistent oral sores.

Before using Nicotinell Spearmint, consider the following safety measures. - Assess nicotine dependence: evaluate the level of dependence and suitability for nicotine replacement therapy. - Cardiovascular risk: avoid use immediately after recent myocardial infarction or unstable angina. - Medical supervision: use under guidance of a healthcare professional, especially for patients with chronic conditions. - Concomitant nicotine products: do not combine with other nicotine replacement therapies to prevent overdose. - Pregnancy and lactation: consult a healthcare provider; safety data are limited. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotinell Spearmint can interact with other substances that affect nicotine metabolism or cardiovascular function.

Major Interactions (Avoid): - Other nicotine replacement therapies: risk of nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): may increase the risk of hypertensive events.

Moderate Interactions (Monitor Closely): - CYP1A2 substrate drugs (e.g., theophylline, clozapine): nicotine may reduce plasma concentrations. - Antidepressants (SSRIs, SNRIs): monitor for enhanced side effects. - Antihypertensive agents: nicotine may attenuate blood‑pressure‑lowering effects.